On pancreatic islets, GLP-1 RAs stimulate glucose-dependent insulin release and inhibit glucagon secretion, improving postprandial glucose control without provoking hypoglycemia—an important feature for insulin-resistant youth and those with prediabetes or type 2 diabetes [9,15]. Here, GLP1R is linked to prediabetes syndrome.